JP2025508676A5 - - Google Patents
Info
- Publication number
- JP2025508676A5 JP2025508676A5 JP2024545962A JP2024545962A JP2025508676A5 JP 2025508676 A5 JP2025508676 A5 JP 2025508676A5 JP 2024545962 A JP2024545962 A JP 2024545962A JP 2024545962 A JP2024545962 A JP 2024545962A JP 2025508676 A5 JP2025508676 A5 JP 2025508676A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263305979P | 2022-02-02 | 2022-02-02 | |
| US63/305,979 | 2022-02-02 | ||
| US202263375803P | 2022-09-15 | 2022-09-15 | |
| US63/375,803 | 2022-09-15 | ||
| US202263384075P | 2022-11-16 | 2022-11-16 | |
| US63/384,075 | 2022-11-16 | ||
| US202263434815P | 2022-12-22 | 2022-12-22 | |
| US63/434,815 | 2022-12-22 | ||
| PCT/US2023/061878 WO2023150638A2 (en) | 2022-02-02 | 2023-02-02 | Omicron coronavirus vaccine constructs and methods of making and using same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025508676A JP2025508676A (ja) | 2025-04-10 |
| JP2025508676A5 true JP2025508676A5 (https=) | 2026-02-10 |
| JPWO2023150638A5 JPWO2023150638A5 (https=) | 2026-02-10 |
Family
ID=87552962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024545962A Pending JP2025508676A (ja) | 2022-02-02 | 2023-02-02 | オミクロンコロナウイルスワクチンコンストラクトならびにこれを作製および使用する方法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4473122A4 (https=) |
| JP (1) | JP2025508676A (https=) |
| KR (1) | KR20240137110A (https=) |
| CN (1) | CN120282795A (https=) |
| AU (1) | AU2023216258A1 (https=) |
| CA (1) | CA3243465A1 (https=) |
| WO (1) | WO2023150638A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250228929A1 (en) * | 2022-04-03 | 2025-07-17 | Icahn School Of Medicine At Mount Sinai | Recombinant newcastle disease viruses and immunogenic compositions for use in immunizing against sars-cov-2 omicron variant |
| CN116987184B (zh) * | 2023-09-26 | 2024-01-12 | 北京百普赛斯生物科技股份有限公司 | 新型冠状病毒bq.1.1突变株特异性抗体及其应用 |
| WO2025202543A1 (en) * | 2024-03-28 | 2025-10-02 | Rokote Laboratories Finland Oy | A vaccine composition comprising an adenoviral vector and an adenoviral vector delivery enhancing agent |
| WO2025250851A1 (en) * | 2024-05-29 | 2025-12-04 | Washington University | Trivalent pan-sarbecovirus mucosal vaccine constructs and methods of making and using same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2716928C (en) * | 2008-03-04 | 2018-04-10 | The Trustees Of The University Of Pennsylvania | Simian adenoviruses sadv-36,-42.1, -42.2, and -44 and uses thereof |
| CA3167833A1 (en) * | 2020-02-14 | 2021-08-19 | Bertrand Victor Gilbert GEORGES | Coronavirus immunogenic compositions and uses thereof |
| MX2022013934A (es) * | 2020-05-07 | 2023-02-22 | Icahn School Med Mount Sinai | Virus de la enfermedad de newcastle recombinante que expresa la proteina de espicula de sars-cov-2 y usos del mismo. |
| WO2021247567A1 (en) * | 2020-06-01 | 2021-12-09 | Washington University | Coronavirus vaccine constructs and methods of making and using same |
-
2023
- 2023-02-02 KR KR1020247029519A patent/KR20240137110A/ko active Pending
- 2023-02-02 CA CA3243465A patent/CA3243465A1/en active Pending
- 2023-02-02 CN CN202380033194.2A patent/CN120282795A/zh active Pending
- 2023-02-02 AU AU2023216258A patent/AU2023216258A1/en active Pending
- 2023-02-02 EP EP23750408.9A patent/EP4473122A4/en active Pending
- 2023-02-02 WO PCT/US2023/061878 patent/WO2023150638A2/en not_active Ceased
- 2023-02-02 JP JP2024545962A patent/JP2025508676A/ja active Pending